300 related articles for article (PubMed ID: 34060205)
1. Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness.
Zhao LJ; Li YY; Zhang YT; Fan QQ; Ren HM; Zhang C; Mardinoglu A; Chen WC; Pang JR; Shen DD; Wang JW; Zhao LF; Zhang JY; Wang ZY; Zheng YC; Liu HM
EMBO Rep; 2021 Aug; 22(8):e50922. PubMed ID: 34060205
[TBL] [Abstract][Full Text] [Related]
2. Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer.
Guo YJ; Pang JR; Zhang Y; Li ZR; Zi XL; Liu HM; Wang N; Zhao LJ; Gao Y; Wang B; Herdewijn P; Jin CY; Liu Y; Zheng YC
Int J Biol Macromol; 2024 Jan; 254(Pt 3):126801. PubMed ID: 37689288
[TBL] [Abstract][Full Text] [Related]
3. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9.
Zhao LJ; Fan QQ; Li YY; Ren HM; Zhang T; Liu S; Maa M; Zheng YC; Liu HM
Pharmacol Res; 2020 Sep; 159():104991. PubMed ID: 32504836
[TBL] [Abstract][Full Text] [Related]
4. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
[TBL] [Abstract][Full Text] [Related]
5. Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer.
Dai XJ; Liu Y; Wang N; Chen HX; Wu JW; Xiong XP; Ji SK; Zhou Y; Shen L; Wang SP; Liu HM; Liu HM; Zheng YC
Eur J Med Chem; 2023 Nov; 259():115684. PubMed ID: 37542989
[TBL] [Abstract][Full Text] [Related]
6. miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
Li B; Xia Y; Lv J; Wang W; Xuan Z; Chen C; Jiang T; Fang L; Wang L; Li Z; He Z; Li Q; Xie L; Qiu S; Zhang L; Zhang D; Xu H; Xu Z
Oncogene; 2021 Oct; 40(43):6180-6194. PubMed ID: 34535770
[TBL] [Abstract][Full Text] [Related]
7. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
Lei ZJ; Wang J; Xiao HL; Guo Y; Wang T; Li Q; Liu L; Luo X; Fan LL; Lin L; Mao CY; Wang SN; Wei YL; Lan CH; Jiang J; Yang XJ; Liu PD; Chen DF; Wang B
Oncogene; 2015 Jun; 34(24):3188-98. PubMed ID: 25893304
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles and cancer stemness in hepatocellular carcinoma - is there a link?
Tian L; Lu J; Ng IO
Front Immunol; 2024; 15():1368898. PubMed ID: 38476233
[TBL] [Abstract][Full Text] [Related]
9. LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.
Shen DD; Pang JR; Bi YP; Zhao LF; Li YR; Zhao LJ; Gao Y; Wang B; Wang N; Wei L; Guo H; Liu HM; Zheng YC
Mol Cancer; 2022 Mar; 21(1):75. PubMed ID: 35296335
[TBL] [Abstract][Full Text] [Related]
10. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
11. The histone LSD1 demethylase in stemness and cancer transcription programs.
Amente S; Lania L; Majello B
Biochim Biophys Acta; 2013 Oct; 1829(10):981-6. PubMed ID: 23684752
[TBL] [Abstract][Full Text] [Related]
12. Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells.
Dai XJ; Zhao LJ; Yang LH; Guo T; Xue LP; Ren HM; Yin ZL; Xiong XP; Zhou Y; Ji SK; Liu HM; Liu HM; Liu Y; Zheng YC
J Med Chem; 2023 Mar; 66(6):3896-3916. PubMed ID: 36856685
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
14. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
[TBL] [Abstract][Full Text] [Related]
15. Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases.
Kim D; Kim KI; Baek SH
J Biomed Sci; 2021 Jun; 28(1):41. PubMed ID: 34082769
[TBL] [Abstract][Full Text] [Related]
16. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.
Zheng YC; Duan YC; Ma JL; Xu RM; Zi X; Lv WL; Wang MM; Ye XW; Zhu S; Mobley D; Zhu YY; Wang JW; Li JF; Wang ZR; Zhao W; Liu HM
J Med Chem; 2013 Nov; 56(21):8543-60. PubMed ID: 24131029
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lysine-specific demethylase 1 enhances the sensitivity of the chemotherapeutic drug doxorubicin in gastric cancer cell.
Zhang XY; Hao P; Wang JW; Zhao W; Liu HM; He PX
Mol Biol Rep; 2023 Jan; 50(1):507-516. PubMed ID: 36352181
[TBL] [Abstract][Full Text] [Related]
18. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the antitumor activities of a potent DCN1 inhibitor compound 383 targeting LSD1 in gastric cancer.
Song Z; Gao K; Asmamaw MD; Liu YJ; Zheng YC; Shi XJ; Liu HM
Eur J Pharmacol; 2022 Feb; 916():174725. PubMed ID: 34953802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
